Home » Cognoptix Test Identifies Alzheimer’s Disease via Beta Amyloid Signature in the Eyes
Cognoptix Test Identifies Alzheimer’s Disease via Beta Amyloid Signature in the Eyes
Meanwhile, Cognoptix has suggested that its SapphireII test can find Alzheimer’s through a beta amyloid signature in the eyes.
Businesswire
Businesswire
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May